{"filing":{"accession_number":"0001493152-26-033662","cik":"0001412486","ticker":"COCP","company_name":"Cocrystal Pharma, Inc.","form":"8-K","filing_date":"2026-07-17","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1412486/000149315226033662/form8-k.htm"},"events":[{"id":18581,"run_id":16705,"accession_number":"0001493152-26-033662","anchor_item_number":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"summary":"The filing discloses results of the 2026 Annual Meeting of Stockholders held on July 14, 2026, including voting outcomes on three proposals: election of five board directors (Proposal 1), ratification of Weinberg \u0026 Company as independent auditor (Proposal 2), and adjournment authority (Proposal 3). This is a classic Item 5.07 shareholder vote results disclosure with detailed vote tallies for each nominee and proposal.","company_name":"Cocrystal Pharma, Inc.","ticker":"COCP","filing_date":"2026-07-17","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":17429,"accession_number":"0001493152-26-033662","item_number":null,"item_title":null,"event_type":"shareholder_vote_results","event_domain":"governance","is_material":true,"confidence":0.98,"reasoning":"The filing discloses results of the 2026 Annual Meeting of Stockholders held on July 14, 2026, including voting outcomes on three proposals: election of five board directors (Proposal 1), ratification of Weinberg \u0026 Company as independent auditor (Proposal 2), and adjournment authority (Proposal 3). This is a classic Item 5.07 shareholder vote results disclosure with detailed vote tallies for each nominee and proposal.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-17T12:01:37.493048+00:00","company_name":"Cocrystal Pharma, Inc.","ticker":"COCP","filing_date":"2026-07-17"}]}